ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,766,647 | +7.7% | 510,109 | +2.7% | 0.08% | +13.0% |
| Q2 2023 | $44,346,757 | -11.3% | 496,882 | +6.5% | 0.07% | -18.8% |
| Q1 2023 | $50,004,452 | -7.0% | 466,372 | +5.9% | 0.08% | -15.0% |
| Q4 2022 | $53,772,875 | -18.4% | 440,292 | -31.0% | 0.10% | -21.9% |
| Q3 2022 | $65,881,000 | +8.6% | 638,001 | -2.3% | 0.13% | +12.3% |
| Q2 2022 | $60,677,000 | -0.5% | 652,724 | +25.6% | 0.11% | +25.3% |
| Q1 2022 | $60,982,000 | -4.8% | 519,612 | +9.1% | 0.09% | +15.2% |
| Q4 2021 | $64,057,000 | -4.6% | 476,154 | +13.0% | 0.08% | -20.2% |
| Q3 2021 | $67,139,000 | +23.8% | 421,227 | +2.1% | 0.10% | +20.7% |
| Q2 2021 | $54,252,000 | +39.2% | 412,411 | +36.4% | 0.08% | +22.4% |
| Q1 2021 | $38,975,000 | +400.4% | 302,422 | +547.7% | 0.07% | +378.6% |
| Q4 2020 | $7,788,000 | +31.3% | 46,694 | +21.5% | 0.01% | +16.7% |
| Q3 2020 | $5,933,000 | +71.1% | 38,441 | +64.0% | 0.01% | +50.0% |
| Q2 2020 | $3,467,000 | +373.6% | 23,440 | +277.2% | 0.01% | +300.0% |
| Q1 2019 | $732,000 | – | 6,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |